Answers are grounded in this paper and cite their sources.
The RTOG 92-02 trial supports the addition of LT adjuvant AD to STAD with RT for T2c-4 PC. In the exploratory subset analysis of patients with Gleason scores 8 to 10, LT adjuvant AD resulted in a survival advantage.
No takes yet. Share an insight, caveat, or question.
Hanks et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: